<DOC>
	<DOC>NCT02242071</DOC>
	<brief_summary>The effect of autologous bone marrow mononuclear cells on Motor Neuron Disease/Amyotrophic Lateral Sclerosis patients.</brief_summary>
	<brief_title>Cell Therapy for Motor Neuron Disease/Amyotrophic Lateral Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<criteria>Patients with the diagnosis of definite Motor Neuron Disease/amyotrophic lateral sclerosis. Age 1880 years HIV/HBV/HCV Malignancies Bleeding tendencies Pneumonia Renal failure Severe liver dysfunction Severe anemia [hb &lt; 8] Any bone marrow disorder Space occupying lesion in brain Pregnancy and lactation Other acute medical conditions/infections such as respiratory infection and pyrexia left ventricular ejection fraction &lt; 25% Patient on artificial ventilatory support</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Motor Neuron Disease</keyword>
	<keyword>Amyotrophic Lateral Sclerosis</keyword>
	<keyword>Autologous Mononuclear Cell therapy</keyword>
	<keyword>Stem cells</keyword>
</DOC>